Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes
Autor: | Vijay Mishra, Prashant Kesharwani, Mohd Cairul Iqbal Mohd Amin, Arun Iyer |
---|---|
EAN: | 9780128097182 |
eBook Format: | ePUB/PDF |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 23.05.2017 |
Kategorie: | |
Schlagworte: | Active targeting Bioadhesion Bioadhesive polymers Biopolymers Buccal delivery Cancer Cancer-targeted drug delivery Cationic liposomes Colloids Controlled release (CR) Cytotoxicity Dendrimers Design of Experiments (DoE) Design space Drug |
89,95 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes provides an overview of the important aspects of nanomedicine in order to illustrate how to design and develop novel and effective drug delivery systems using nanotechnology. The book is organized into three sections, beginning with an introduction to nanomedicine and its associated issues. Section two discusses the latest technologies in nanomedicine, while the third section covers future developments and challenges in the field. By focusing on the design, synthesis, and application of a variety of nanocarriers in drug and gene delivery, this book provides pharmaceutical and materials science students, professors, clinical researchers, and industry scientists with a valuable resource aimed at tackling the challenges of delivering drugs and genes in a more targeted manner. - Explores a wide range of promising approaches for the diagnosis and treatment of diseases using the latest advances in cutting-edge nanomedical technologies - Contains contributions from world-renowned experts and researchers working in the area of nanomedicine and drug delivery - Covers the associated challenges and potential solutions to working with nanotechnology in drug delivery - Highlights crucial topics, such as biopharmaceutical and toxicity issues, quality by design, drug targeting, and more